M
1.33
-0.01 (-0.75%)
Penutupan Terdahulu | 1.34 |
Buka | 1.35 |
Jumlah Dagangan | 85,490 |
Purata Dagangan (3B) | 1,327,450 |
Modal Pasaran | 22,503,068 |
Harga / Buku (P/B) | 7.95 |
Julat 52 Minggu |
EPS Cair (TTM) | -0.510 |
Jumlah Hutang/Ekuiti (D/E MRQ) | 0.04% |
Nisbah Semasa (MRQ) | 3.99 |
Aliran Tunai Operasi (OCF TTM) | -5.56 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.72 M |
Pulangan Atas Aset (ROA TTM) | -127.59% |
Pulangan Atas Ekuiti (ROE TTM) | -238.90% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - General (US) | Menurun | Bercampur |
Drug Manufacturers - General (Global) | Menurun | Bercampur | |
Stok | MIRA Pharmaceuticals, Inc. | Bercampur | - |
AISkor Stockmoo
-0.9
Konsensus Penganalisis | -2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 0.5 |
Purata | -0.88 |
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - General |
% Dimiliki oleh Orang Dalam | 19.80% |
% Dimiliki oleh Institusi | 6.98% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Cross Staff Investments Inc | 31 Mar 2025 | 363,401 |
Suncoast Equity Management | 31 Mar 2025 | 103,289 |
J.W. Cole Advisors, Inc. | 31 Mar 2025 | 40,000 |
First American Bank | 31 Mar 2025 | 20,000 |
Praetorian Wealth Management, Inc. | 31 Mar 2025 | 17,500 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |